|
BCKDHA expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1932999999974E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.110500E-02 |
| Normal-vs-Stage2 |
8.520600E-03 |
| Normal-vs-Stage3 |
1.43349999981446E-07 |
| Normal-vs-Stage4 |
4.4145999966716E-08 |
| Stage1-vs-Stage2 |
1.710580E-01 |
| Stage1-vs-Stage3 |
1.68783999999755E-05 |
| Stage1-vs-Stage4 |
6.42750000001691E-07 |
| Stage2-vs-Stage3 |
9.260000E-02 |
| Stage2-vs-Stage4 |
2.245600E-02 |
| Stage3-vs-Stage4 |
3.505600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.5511699999915E-05 |
| Normal-vs-AfricanAmerican |
1.026630E-01 |
| Normal-vs-Asian |
5.785600E-01 |
| Caucasian-vs-AfricanAmerican |
1.840390E-01 |
| Caucasian-vs-Asian |
3.757200E-01 |
| AfricanAmerican-vs-Asian |
7.571200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0051000000354E-06 |
| Normal-vs-Female |
5.200100E-03 |
| Male-vs-Female |
4.142300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.78030000000229E-05 |
| Normal-vs-Age(41-60Yrs) |
4.820400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.176080E-04 |
| Normal-vs-Age(81-100Yrs) |
2.443500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.302300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.998200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.916400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.269600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.325600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.514600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.606800E-01 |
| Normal-vs-Grade 2 |
3.637700E-03 |
| Normal-vs-Grade 3 |
4.588700E-04 |
| Normal-vs-Grade 4 |
1.36289979302262E-10 |
| Grade 1-vs-Grade 2 |
1.604190E-02 |
| Grade 1-vs-Grade 3 |
1.750250E-02 |
| Grade 1-vs-Grade 4 |
1.99000999999699E-05 |
| Grade 2-vs-Grade 3 |
5.067000E-01 |
| Grade 2-vs-Grade 4 |
3.35349999991408E-07 |
| Grade 3-vs-Grade 4 |
4.21000000000449E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.468400E-01 |
| Normal-vs-ccB subtype |
1.54970003496402E-09 |
| ccA subtype-vs-ccB subtype |
4.54159998497516E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64159999999081E-05 |
| Normal-vs-N1 |
1.314370E-01 |
| N0-vs-N1 |
8.219400E-01 |
|
|
